Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 22.9% in First Half of 2022

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 270.6 million yuan in the first half of 2022, up 22.9% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 10.9% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 42.3%.